ARCHIVES

SEC Notifies ImClone It May Bring Action Against Company

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

Epstein Back With New Attack On “Establishment” In Congressional Record

November 6, 1987

New Jersey Center To Have Two Alliances: One With CINJ—and One With MD Anderson

June 21, 2013

Court Agreement Clears The Way For Human Gene Transplant Study

May 26, 1989

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005